Cargando…
GNX-4728, a novel small molecule drug inhibitor of mitochondrial permeability transition, is therapeutic in a mouse model of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder in humans characterized by progressive degeneration of skeletal muscle and motor neurons in spinal cord, brainstem, and cerebral cortex causing skeletal muscle paralysis, respiratory insufficiency, and death. There are no cures or...
Autores principales: | Martin, Lee J., Fancelli, Daniele, Wong, Margaret, Niedzwiecki, Mark, Ballarini, Marco, Plyte, Simon, Chang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271619/ https://www.ncbi.nlm.nih.gov/pubmed/25565966 http://dx.doi.org/10.3389/fncel.2014.00433 |
Ejemplares similares
-
Quantification of active mitochondrial permeability transition pores using GNX-4975 inhibitor titrations provides insights into molecular identity
por: Richardson, Andrew P., et al.
Publicado: (2016) -
Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis
por: Jiang, Zhen, et al.
Publicado: (2015) -
Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis
por: Cozzolino, Mauro, et al.
Publicado: (2015) -
The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
por: Zhao, Jiantao, et al.
Publicado: (2022) -
Mitochondrial Transport and Turnover in the Pathogenesis of Amyotrophic Lateral Sclerosis
por: Granatiero, Veronica, et al.
Publicado: (2019)